Clik here to view.
科兴新冠疫苗获准紧急用于巴西3至5岁儿童
北京 (美国商业资讯)–中国领先的生物制药产品供应商科兴控股生物技术有限公司（Sinovac Biotech Ltd.，以下简称“科兴”或“公司”）(NASDAQ: SVA)宣布，公司新冠疫苗克尔来福(CoronaVac)于7月13日获得巴西卫生监管局(Anvisa)的批准，紧急用于3至5岁儿童。这些儿童将与6至17岁的未成年人和成年人接种相同的剂量，并且该疫苗对3至5...
View ArticleClik here to view.
中外制药：骨质疏松症治疗产品 艾地罗®在中国上市的通知
东京 (美国商业资讯)–中外制药株式会社(总部:东京，总裁兼首席执行官:奥田 修)在中国的全资子公司日健中外制药有限公司(总部:泰州市，董事长:幸松邦彦)将于今天在中国上市由中外制药研发的活性维生素D3衍生物 艾地罗®(通用名:艾地骨化醇,中文名:艾地罗®)，适应症为“绝经后女性骨质疏松症”。本产品已经于2020年12月获得中国国家药品监督管理局 (NMPA) 的批准。...
View ArticleClik here to view.
Dermaliq任命药学博士Gordon Dow、Michael Kuligowski, MD博士、R. Todd Plott, MD以及Xavier...
特拉华州威尔明顿 (美国商业资讯)–专注于皮肤病治疗的私营生物制药公司Dermaliq Therapeutics, Inc. (Dermaliq)今天宣布成立科学和医学顾问委员会，成员均为国际知名皮肤病学专家，包括Gordon Dow（美国旧金山）、Xavier Yon（法国巴黎）、Michael Kuligowski, MD博士（美国查兹福德）以及R. Todd Plott,...
View ArticleClik here to view.
HCL Technologies to Accelerate Digital Transformation at DSM
NOIDA, India & HEERLEN, Netherlands HCL Technologies (HCL), a leading global technology company, has signed a multi-year deal to drive the modernization of DSM’s core IT business systems and...
View ArticleClik here to view.
Peoplecare Chooses Boomi and Atturra To Connect Member Data For Personalized...
CHESTERBROOK, Pa. Boomi™, the intelligent connectivity and automation leader, today announced that Peoplecare, an Australian health insurance mutual fund, implemented The Boomi AtomSphere™ Platform...
View ArticleClik here to view.
Peoplecare选用Boomi和Atturra来连接会员数据，以提供个性化的健康基金体验
宾夕法尼亚州切斯特布鲁克 (美国商业资讯)–智能连接和自动化领导者Boomi™今天宣布，澳大利亚健康保险共同基金Peoplecare采用了Boomi AtomSphere™平台，通过互联、准确和可访问的数据提供更好的会员体验和个性化的健康保险服务。 本新闻稿包含多媒体。此处查看新闻稿全文：...
View ArticleClik here to view.
シノバックのCOVID-19ワクチンがブラジルで3～5歳の小児への緊急使用承認を取得
北京 （ビジネスワイヤ） — 中国でバイオ医薬品を提供する一流企業であるシノバック・バイオテック（「シノバック」または「当社」）（NASDAQ:...
View ArticleClik here to view.
SINOVAC Initiates Clinical Trial for Its Quadrivalent Influenza Vaccine in Chile
BEIJING Sinovac Biotech Ltd. (“SINOVAC” or the “Company”) (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced that a phase III clinical trial for SINOVAC’s...
View ArticleClik here to view.
Trinity Life Sciences Acquires D Cube Analytics
WALTHAM, Mass. Trinity Life Sciences, a leader in global life sciences commercialization solutions, announced the acquisition of Illinois-headquartered D Cube Analytics. The acquisition adds...
View ArticleClik here to view.
MedTech Innovator Names 20 Premier Startups for Annual Asia Pacific Accelerator
LOS ANGELES & SINGAPORE MedTech Innovator, the largest accelerator of medical technology companies in the world, in partnership with Asia Pacific Medical Technology Association (APACMed), the...
View ArticleClik here to view.
ATLATL Boosts China’s Life Sciences through Integration of Global Innovation...
SHANGHAI Celebrating its 5th anniversary, ATLATL proclaims that it will continue contributing to the rapid growth of the life sciences sector in China. The ATLATL Center for Innovation &...
View ArticleClik here to view.
科兴四价流感疫苗在智利启动临床试验
北京 (美国商业资讯)–中国领先的生物医药产品供应商科兴控股生物技术有限公司（Sinovac Biotech Ltd.，以下简称“科兴”或“公司”）(NASDAQ: SVA)宣布，公司已与智利天主教大学（首席研究员Pablo González博士）合作，在智利共和国启动灭活四价流感疫苗的III期临床试验。研究结果将为科兴流感疫苗的免疫原性和保护能力提供科学证据。...
View ArticleClik here to view.
シノバックがチリで4価インフルエンザワクチンの臨床試験を開始
北京 （ビジネスワイヤ） — 中国でバイオ医薬品を提供する一流企業であるシノバック・バイオテック（「シノバック」または「当社」）（NASDAQ: SVA）は、当社の不活化4価インフルエンザワクチンの第3相臨床試験をチリ共和国で、チリ・カトリック大学（Pontificia Universidad Católica de...
View ArticleClik here to view.
Clik here to view.
Clik here to view.
Biocytogen and LiberoThera Achieve Milestone Progress in Co-Development of...
BEIJING, China & TOKYO February 1st 2021, Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”) entered a strategic collaboration with LiberoThera Co., Ltd (“LiberoThera”) to co-develop...
View ArticleClik here to view.
First Patient Dosed in CANbridge Pharmaceuticals CAN103 Phase 1/2 Trial for...
BEIJING & CAMBRIDGE, Mass. CANbridge Pharmaceuticals Inc. (HKEX:1228), a China and US-based global biopharmaceutical company committed to the research, development and commercialization of...
View ArticleClik here to view.
Biocytogenとリベロセラ株式会社の戦略的共同研究成果について
中国北京と日本東京 （ビジネスワイヤ） –バイオサイトジェン（北京）製薬株式会社（Biocytogen Pharmaceuticals（Beijing）Co., Ltd. 以下、「Biocytogen」）とリベロセラ株式会社（LiberoThera Co., Ltd....
View ArticleClik here to view.
Biocytogen and LiberoThera Achieve Milestone Progress in Co-Development of...
BEIJING & TOKYO February 1st 2021, Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”) entered a strategic collaboration with LiberoThera Co., Ltd (“LiberoThera”) to co-develop fully...
View ArticleClik here to view.
Cell and Gene Therapy Industry Comes Together for Matica Bio’s New Global Event
COLLEGE STATION, Texas Matica Biotechnology, Inc. (Matica Bio), a contract development and manufacturing organization (CDMO) specializing in the clinical and commercial production of cell and gene...
View Article